Form 4: Alkermes Director Frank Anders Wilson Reports Stock Transactions

Director Frank Anders Wilson reports the disposition of Alkermes plc ordinary shares following the vesting of restricted stock units.

Summary

• Frank Anders Wilson, a director of Alkermes plc, reported transactions involving the company's ordinary shares on June 29, 2024.
• These transactions involved the disposition of 6,104 shares to cover tax obligations related to the vesting of restricted stock units.
• Additionally, 1,465 shares were disposed of at a price of $24.1.
• Following these transactions, Wilson directly owns 24,995 ordinary shares.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the filing simply reports stock transactions related to vested equity compensation. It doesn't inherently indicate positive or negative sentiment about the company's prospects.

Industry Context

Form 4 filings are standard practice for reporting insider transactions and provide transparency to the market regarding the buying and selling activities of company insiders.

Comparison to Industry Standards

• Monitoring insider transactions is a common practice in the pharmaceutical industry to gauge management's sentiment and potential future performance.
• Comparing the volume and frequency of insider transactions at Alkermes to those of peers like Biogen or Vertex Pharmaceuticals can provide insights into relative valuation and outlook.

Stakeholder Impact

• The transactions may have a minor impact on shareholders by slightly increasing the available float of Alkermes shares.

Key Dates